Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.
Carles J, Medina-Lopez RA, Puente J, Gómez-Ferrer Á, Nebra JC, Sáez Medina MI, Ribal MJ, Antolín AR, Álvarez-Ossorio JL, Suárez Novo JF, Agut CM, Srinivasan S, Ortiz J, Fizazi K. Carles J, et al. Among authors: ribal mj. Future Oncol. 2023 Apr;19(12):819-828. doi: 10.2217/fon-2022-1131. Epub 2023 May 24. Future Oncol. 2023. PMID: 37222151 Free article. Clinical Trial.
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer.
Amseian G, Figueras M, Mases J, Mengual L, Ribal MJ, Quintero K, Pages R, Ingelmo-Torres M, Roldan FL, Caratini R, Fuster D, Alcaraz A, Izquierdo L, Paredes P; Clinic Barcelona Nuclear Medicine (CBNM) Group. Amseian G, et al. Among authors: ribal mj. EJNMMI Res. 2024 Dec 18;14(1):124. doi: 10.1186/s13550-024-01170-x. EJNMMI Res. 2024. PMID: 39694939 Free PMC article.
p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-independent Penile Squamous Cell Carcinomas With Adverse Prognosis.
Trias I, Algaba F, de Torres I, Saco A, Marimon L, Peñuelas N, Diez-Ahijado L, Sisuashvili L, Darecka K, Morató A, Del Pino M, Ferrándiz-Pulido C, Ribal MJ, Ajami T, Corral JM, Gaya JM, Reig O, Ordi O, Ribera-Cortada I, García-Herrera A, Rakislova N. Trias I, et al. Among authors: ribal mj. Am J Surg Pathol. 2025 Feb 1;49(2):190-193. doi: 10.1097/PAS.0000000000002341. Epub 2024 Dec 10. Am J Surg Pathol. 2025. PMID: 39654380 No abstract available.
Best Practice in Using Social Media: The European Association of Urology Position Statement.
Yuen-Chun Teoh J, Bhatt NR, Cucchiara V, Garcia Rojo E, Gauhar V, Mercader C, Pradere B, Verla W, Darraugh J, Bezuidenhout C, van Gurp M, Hesston E, Bloemberg J, N'Dow J, Ribal MJ, Giannarini G; European Association of Urology Guidelines Office Dissemination Committee. Yuen-Chun Teoh J, et al. Among authors: ribal mj. Eur Urol. 2024 Oct 28:S0302-2838(24)02679-4. doi: 10.1016/j.eururo.2024.10.018. Online ahead of print. Eur Urol. 2024. PMID: 39472201
Role of Liquid Biopsy in Progressive PSA Patients after Radical Prostatectomy.
Figueras M, Mengual L, Ingelmo-Torres M, Roldán FL, Padullés B, Alfambra H, Herranz S, Paredes P, Amseian G, Mases J, Ribal MJ, Izquierdo L, Alcaraz A. Figueras M, et al. Among authors: ribal mj. Diagnostics (Basel). 2024 Oct 16;14(20):2293. doi: 10.3390/diagnostics14202293. Diagnostics (Basel). 2024. PMID: 39451616 Free PMC article.
Intravenous indocyanine green to evaluate distal ureteral vascularity during robot-assisted radical cystectomy with intracorporeal urinary diversion.
Carbonell E, Sierra A, Mercader C, Peradejordi M, Muní M, Tello A, Alfambra H, Martínez C, Ajami T, Izquierdo L, Vilaseca A, Ribal MJ, Alcaraz A, Martos R, Musquera M. Carbonell E, et al. Among authors: ribal mj. World J Urol. 2024 Oct 8;42(1):568. doi: 10.1007/s00345-024-05284-8. World J Urol. 2024. PMID: 39379730
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.
Lawlor A, Beyer K, Russell B, Steinbeisser C, Bjartell A, De Meulder B, Omar MI, Hulsen T, Butler J, N'Dow J, Rivas JG, Gandaglia G, Nicoletti R, Sakalis V, Smith EJ, Maass M, Zong J, Fullwood L, Abbott T, Tafreshiha A, Papineni K, Snijder R, Horgan D, Seager S, Evans-Axelsson S, Ribal MJ, Roobol MJ, Van Hemelrijck M; PIONEER Consortium. Lawlor A, et al. Among authors: ribal mj. Nat Rev Urol. 2024 Sep 9. doi: 10.1038/s41585-024-00925-4. Online ahead of print. Nat Rev Urol. 2024. PMID: 39251785 Review.
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer.
Beijert IJ, Hagberg O, Gårdmark T, Holmberg L, Häggström C, Johnston A, Trail M, Hamid S, Dreyer BA, Padovani L, Garau R, Hasan R, Ahmad I, Hendry D, Compérat EM, Burger M, Rouprêt M, Gontero P, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, Mariappan P, Liedberg F, van Rhijn BWG; BladderBaSe-Consortium; Scot BC Quality OPS Collaborative; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973; WHO2004/2016 Classification Systems for Grade. Beijert IJ, et al. Among authors: ribal mj. Eur Urol. 2024 Nov;86(5):391-399. doi: 10.1016/j.eururo.2024.08.013. Epub 2024 Aug 29. Eur Urol. 2024. PMID: 39209674 Free article.
189 results